JPMORGAN CHASE & CO - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$50,826,711
-32.2%
1,232,162
-8.3%
0.01%
-25.0%
Q2 2023$75,011,687
+5.6%
1,343,332
+5.5%
0.01%
-11.1%
Q1 2023$71,006,000
+154311.2%
1,272,735
+0.9%
0.01%
+50.0%
Q4 2022$45,985
-99.9%
1,261,900
+4.6%
0.01%
+20.0%
Q3 2022$34,358,000
-24.8%
1,206,404
+19.5%
0.01%
-16.7%
Q2 2022$45,698,000
+617.3%
1,009,922
+1105.7%
0.01%
+500.0%
Q1 2022$6,371,000
-71.0%
83,761
-43.2%
0.00%
-66.7%
Q4 2021$21,950,000
-33.7%
147,354
-35.2%
0.00%
-25.0%
Q3 2021$33,127,000
+264.8%
227,553
+390.6%
0.00%
+300.0%
Q2 2021$9,081,000
-50.9%
46,378
-54.6%
0.00%
-50.0%
Q1 2021$18,506,000
-11.9%
102,245
-31.1%
0.00%
-33.3%
Q4 2020$21,000,000
-8.8%
148,302
-19.5%
0.00%
-25.0%
Q3 2020$23,025,000
-6.5%
184,244
-33.2%
0.00%
-20.0%
Q2 2020$24,623,000
+61.8%
275,700
+12.9%
0.01%
+25.0%
Q1 2020$15,222,000
-25.9%
244,257
-9.3%
0.00%0.0%
Q4 2019$20,534,000
+89.4%
269,306
+25.2%
0.00%
+100.0%
Q3 2019$10,843,000215,1510.00%
Other shareholders
10X GENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Venrock Management VI, LLC 962,309$188,439,00095.08%
Foresite Capital Management II, LLC 1,753,528$343,376,00092.37%
Foresite Capital Management I, LLC 750,000$146,865,00088.53%
12 West Capital Management LP 1,922,000$376,366,00015.78%
Financial Consulate Inc. 141,258$27,661,0009.97%
FINANCIAL CONSULATE, INC 141,258$27,661,0009.97%
Meritech Capital Associates V L.L.C. 1,793,871$351,276,0007.51%
Andar Capital Management HK Ltd 51,000$9,987,0006.81%
JS Capital Management LLC 540,589$105,858,0005.12%
Renaissance Capital LLC 97,281$19,050,0003.01%
View complete list of 10X GENOMICS INC shareholders